Seeing Is Believing
Analyst Chris Cooper, currently employed at GOLDMAN SACHS,
Most recent stock forecast was given on RMD, ResMed at 19-Jul-2025.
Analyst best performing recommendations are on RMD (RESMED).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$290
$35.6 (13.99%)
$286
2 months 24 days ago
(24-Apr-2025)
14/18 (77.78%)
$53.9 (22.83%)
310
Hold
$248
$-6.4 (-2.52%)
$260
2 months 24 days ago
(24-Apr-2025)
2/3 (66.67%)
$11.9 (5.04%)
19
Buy
$285
$30.6 (12.03%)
$250
2 months 24 days ago
(24-Apr-2025)
5/6 (83.33%)
$48.9 (20.71%)
30
Hold
5 months 17 days ago
(31-Jan-2025)
11/11 (100%)
$-7.67 (-3.15%)
212
Buy
$250
$-4.4 (-1.73%)
$215
9 months 18 days ago
(30-Sep-2024)
11/11 (100%)
$6.95 (2.86%)
115